Release of noradrenaline from sympathetic endings.
D000109:Acetylcholine / Q000494:pharmacology / Q000502:physiology*; D000818:Animals; D001338:Autonomic Fibers, Postganglionic / Q000187:drug effects / Q000502:physiology*; D001949:Bretylium Compounds / Q000494:pharmacology; D006145:Guanethidine / Q000494:pharmacology; D006426:Hemicholinium 3 / Q000494:pharmacology; D066298:In Vitro Techniques; D007531:Isoflurophate / Q000494:pharmacology; D008638:Mesenteric Arteries; D008854:Microscopy, Electron; D009388:Neostigmine / Q000494:pharmacology; D009411:Nerve Endings / Q000166:cytology; D009638:Norepinephrine / Q000378:metabolism*; D010477:Perfusion; D010870:Pineal Gland / Q000294:innervation; D010880:Piperidines / Q000494:pharmacology; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D051381:Rats; D013564:Sympathetic Nervous System / Q000166:cytology / Q000502:physiology*
D001949:Bretylium Compounds; D010880:Piperidines; D000644:Quaternary Ammonium Compounds; D007531:Isoflurophate; D006426:Hemicholinium 3; D009388:Neostigmine; D000109:Acetylcholine; D009638:Norepinephrine; D006145:Guanethidine